Publication & Citation Trends
Publications
71 total
The anti-GD2 monoclonal antibody naxitamab plus GM-CSF for relapsed or refractory high-risk neuroblastoma: a phase 2 clinical trial PDF
Cited by 22
OpenAlex
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study PDF
Cited by 43
OpenAlex
Inotuzumab ozogamicin combined with chemotherapy in pediatric B-cell precursor CD22<sup>+</sup> acute lymphoblastic leukemia: results of the phase IB ITCC-059 trial PDF
Cited by 17
OpenAlex
BEACON-Immuno: Results of the dinutuximab beta (dB) randomization of the BEACON-Neuroblastoma phase 2 trial—A European Innovative Therapies for Children with Cancer (ITCC–International Society of Paediatric Oncology Europe Neuroblastoma Group (SIOPEN) trial.
Cited by 30
OpenAlex
Impact of COVID-19 in paediatric early-phase cancer clinical trials in Europe: A report from the Innovative Therapies for Children with Cancer (ITCC) consortium PDF
Cited by 22
OpenAlex
Research Topics
Neuroblastoma Research and Treatments
(17)
Acute Lymphoblastic Leukemia research
(13)
Childhood Cancer Survivors' Quality of Life
(12)
Pharmaceutical studies and practices
(11)
Ethics in Clinical Research
(8)
Affiliations
Universidad Complutense de Madrid
Istituto Giannina Gaslini
Research Institute Hospital 12 de Octubre
Molina Center for Energy and the Environment
Hospital Universitario 12 De Octubre